A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 441,344 shares of BMY stock, worth $25.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
441,344
Previous 445,254 0.88%
Holding current value
$25.5 Million
Previous $18.5 Million 23.51%
% of portfolio
0.15%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$39.66 - $51.75 $155,070 - $202,342
-3,910 Reduced 0.88%
441,344 $22.8 Million
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $57,758 - $76,040
-1,435 Reduced 0.32%
445,254 $18.5 Million
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $52,921 - $60,003
1,103 Added 0.25%
446,689 $24.2 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $1.24 Million - $1.48 Million
25,535 Added 6.08%
445,586 $22.9 Million
Q3 2023

Nov 09, 2023

BUY
$57.89 - $64.73 $3.11 Million - $3.47 Million
53,656 Added 14.64%
420,051 $24.4 Million
Q2 2023

Aug 09, 2023

BUY
$63.71 - $70.74 $379,584 - $421,468
5,958 Added 1.65%
366,395 $23.4 Million
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $68,601 - $77,809
1,044 Added 0.29%
360,437 $25 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $3.22 Million - $3.82 Million
47,071 Added 15.07%
359,393 $25.9 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $302 - $179,037
2,330 Added 0.75%
312,322 $22.2 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $1.33 Million - $1.47 Million
18,341 Added 6.29%
309,992 $23.9 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $802,068 - $961,751
13,046 Added 4.68%
291,651 $21.3 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $7,347 - $8,565
137 Added 0.05%
278,605 $17.4 Million
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $83,962 - $98,350
-1,419 Reduced 0.51%
278,468 $16.5 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $19,996 - $21,776
-323 Reduced 0.12%
279,887 $18.7 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $127,581 - $143,491
-2,150 Reduced 0.76%
280,210 $17.7 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $4.25 Million - $4.81 Million
73,523 Added 35.21%
282,360 $17.5 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $4.56 Million - $5.06 Million
79,454 Added 61.41%
208,837 $12.6 Million
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $1.12 Million - $1.31 Million
-20,382 Reduced 13.61%
129,383 $7.61 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $55,308 - $80,376
-1,192 Reduced 0.79%
149,765 $8.35 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $2.27 Million - $2.96 Million
46,137 Added 44.02%
150,957 $9.69 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $745,395 - $883,773
17,428 Added 19.94%
104,820 $5.32 Million
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $359,547 - $397,581
-8,058 Reduced 8.44%
87,392 $3.96 Million
Q1 2019

May 07, 2019

BUY
$45.12 - $53.8 $289,083 - $344,696
6,407 Added 7.2%
95,450 $4.55 Million
Q4 2018

Feb 11, 2019

SELL
$48.76 - $63.23 $2.19 Million - $2.84 Million
-44,871 Reduced 33.51%
89,043 $4.63 Million
Q3 2018

Nov 08, 2018

SELL
$55.19 - $62.25 $2.05 Million - $2.32 Million
-37,192 Reduced 21.74%
133,914 $8.31 Million
Q2 2018

Aug 03, 2018

BUY
$50.53 - $62.98 $1.26 Million - $1.58 Million
25,020 Added 17.13%
171,106 $9.47 Million
Q1 2018

May 09, 2018

SELL
$59.92 - $68.98 $18,754 - $21,590
-313 Reduced 0.21%
146,086 $9.24 Million
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $780,958 - $851,445
13,029 Added 9.77%
146,399 $8.97 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $7.37 Million - $8.5 Million
133,370
133,370 $8.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.